12:00 AM
Sep 16, 2013
 |  BC Week In Review  |  Company News  |  Other News

Biotec Services International Ltd., Oxford BioMedica, Cell Therapy Catapult, Cranfield University, Heart of England NHS Foundation Trust gene/cell therapy news

A consortium led by Oxford BioMedica was awarded £7.7 million ($12.1 million) from the U.K. government through its Advanced Manufacturing Supply Chain Initiative (AMSCI) to develop a "centre of excellence" in advanced therapy medicinal product (ATMP) supply...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >